{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T06:10:57Z","timestamp":1766643057260,"version":"3.48.0"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,24]]},"DOI":"10.7759\/cureus.100037","type":"journal-article","created":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T06:08:56Z","timestamp":1766642936000},"source":"Crossref","is-referenced-by-count":0,"title":["Circulating Viral Antigenic Proteins and Inflammatory Biomarkers in Influenza and Respiratory Syncytial Virus Infections: Associations With Disease Severity and Transmission"],"prefix":"10.7759","author":[{"given":"Kailash","family":"Chandra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayan  K","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhumika","family":"Upadhyay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azhar","family":"Uddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed M","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farzana","family":"Islam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasir","family":"Alvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richa","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaspreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabina","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachna","family":"Tewari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Influenza (seasonal). (2025). https.\/\/www.who.int\/news-room\/fact-sheets\/detail\/influenza-(seasonal)."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.46010","article-title":"Hospitalization following outpatient diagnosis of respiratory syncytial virus in adults","volume":"7","author":"Landi SN","year":"2024","unstructured":"Landi SN, Garofalo DC, Reimbaeva M, et al.. Hospitalization following outpatient diagnosis of respiratory syncytial virus in adults. JAMA Netw Open. 2024, 7:e2446010. 10.1001\/jamanetworkopen.2024.46010","journal-title":"JAMA Netw Open"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/bmjph-2024-001727","article-title":"Resource utilisation and cost of hospitalisation with community-acquired pneumonia among older adults in India, 2018-2020","volume":"3","author":"Prabhakaran AO","year":"2025","unstructured":"Prabhakaran AO, Amarchand R, Kanungo S, et al.. Resource utilisation and cost of hospitalisation with community-acquired pneumonia among older adults in India, 2018-2020. BMJ Public Health. 2025, 3:e001727. 10.1136\/bmjph-2024-001727","journal-title":"BMJ Public Health"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0323465","article-title":"Assessing influenza activity variations in the Asian region during the pre- and post-pandemic period (2017-2023)","volume":"1","author":"Nisar N","year":"2025","unstructured":"Nisar N, Badar N, Safdar I. Assessing influenza activity variations in the Asian region during the pre- and post-pandemic period (2017-2023). PLoS One. 2025, 1:0323465. 10.1371\/journal.pone.0323465","journal-title":"PLoS One"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124122","article-title":"Dynamics of Influenza Seasonality at Sub-Regional Levels in India and Implications for Vaccination Timing","volume":"4","author":"Chadha MS","year":"2015","unstructured":"Chadha MS, Potdar VA, Saha S, et al.. Dynamics of Influenza Seasonality at Sub-Regional Levels in India and Implications for Vaccination Timing. PLoS One. 2015, 4:0124122. 10.1371\/journal.pone.0124122","journal-title":"PLoS One"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-025-11421-4","article-title":"Epidemiology and surveillance of influenza, RSV and SARS-CoV-2 in children admitted with severe acute respiratory infection in West bengal, India from 2022 to 2023","volume":"25","author":"Khan T","year":"2025","unstructured":"Khan T, Das RS, Jaiswal A, et al.. Epidemiology and surveillance of influenza, RSV and SARS-CoV-2 in children admitted with severe acute respiratory infection in West bengal, India from 2022 to 2023. BMC Infect Dis. 2025, 25:1047. 10.1186\/s12879-025-11421-4","journal-title":"BMC Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1218292","article-title":"Pan-India influenza-like illness (ILI) and severe acute respiratory infection (SARI) surveillance: epidemiological, clinical and genomic analysis","volume":"11","author":"Potdar V","year":"2023","unstructured":"Potdar V, Vijay N, Mukhopadhyay L, et al.. Pan-India influenza-like illness (ILI) and severe acute respiratory infection (SARI) surveillance: epidemiological, clinical and genomic analysis. Front Public Health. 2023, 11:1218292. 10.3389\/fpubh.2023.1218292","journal-title":"Front Public Health"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-025-02924-2","article-title":"Respiratory viral infections in hospitalized adults: a comparative clinico-laboratory study of RSV, HMPV, and influenza","volume":"22","author":"Devadiga S","year":"2025","unstructured":"Devadiga S, Varamballi P, Shetty U, Mukhopadhyay C, Jayaram A. Respiratory viral infections in hospitalized adults: a comparative clinico-laboratory study of RSV, HMPV, and influenza. Virol J. 2025, 22:294. 10.1186\/s12985-025-02924-2","journal-title":"Virol J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiae171","article-title":"Respiratory syncytial virus vs influenza virus infection: mortality and morbidity comparison over 7 epidemic seasons in an elderly population","volume":"230","author":"Recto CG","year":"2024","unstructured":"Recto CG, Fourati S, Khellaf M, et al.. Respiratory syncytial virus vs influenza virus infection: mortality and morbidity comparison over 7 epidemic seasons in an elderly population. J Infect Dis. 2024, 230:1130-8. 10.1093\/infdis\/jiae171","journal-title":"J Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104685","article-title":"Severity of influenza virus and respiratory syncytial virus coinfections in hospitalized adult patients","volume":"133","author":"Zhang Y","year":"2020","unstructured":"Zhang Y, Zhao J, Zou X, et al.. Severity of influenza virus and respiratory syncytial virus coinfections in hospitalized adult patients. J Clin Virol. 2020, 133:104685. 10.1016\/j.jcv.2020.104685","journal-title":"J Clin Virol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1099\/jgv.0.000535","article-title":"Filamentous influenza viruses","volume":"97","author":"Dadonaite B","year":"2016","unstructured":"Dadonaite B, Vijayakrishnan S, Fodor E, Bhella D, Hutchinson EC. Filamentous influenza viruses. J Gen Virol. 2016, 97:1755-64. 10.1099\/jgv.0.000535","journal-title":"J Gen Virol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2023.2223057","article-title":"Pathogenicity and virulence of influenza","volume":"14","author":"Liang Y","year":"2023","unstructured":"Liang Y. Pathogenicity and virulence of influenza. Virulence. 2023, 14:2223057. 10.1080\/21505594.2023.2223057","journal-title":"Virulence"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a038398","article-title":"Structure and function of the influenza virus transcription and replication machinery","volume":"10","author":"Fodor E","year":"2020","unstructured":"Fodor E, Te Velthuis AJ. Structure and function of the influenza virus transcription and replication machinery. Cold Spring Harb Perspect Med. 2020, 10:a038398. 10.1101\/cshperspect.a038398","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-018-0002-y","article-title":"Influenza","volume":"4","author":"Krammer F","year":"2018","unstructured":"Krammer F, Smith GJD, Fouchier RAM, et al.. Influenza. Nat Rev Dis Primers. 2018, 4:1.","journal-title":"Nat Rev Dis Primers"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz010","article-title":"Antibody determinants of influenza immunity","volume":"219","author":"Crowe JE Jr","year":"2019","unstructured":"Crowe JE Jr. Antibody determinants of influenza immunity. J Infect Dis. 2019, 219:19-21. 10.1093\/infdis\/jiz010","journal-title":"J Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8030409","article-title":"Influenza neuraminidase: a neglected protein and its potential for a better influenza vaccine","volume":"8","author":"Giurgea LT","year":"2020","unstructured":"Giurgea LT, Morens DM, Taubenberger JK, et al.. Influenza neuraminidase: a neglected protein and its potential for a better influenza vaccine. Vaccines. 2020, 8:409. 10.3390\/vaccines8030409","journal-title":"Vaccines"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/0300060519845488","article-title":"Virus-induced pathogenesis, vaccine development, and diagnosis of novel H7N9 avian influenza A virus in humans: a systemic literature review","volume":"48","author":"Wang WH","year":"2020","unstructured":"Wang WH, Erazo EM, Ishcol MR, Lin CY, Assavalapsakul W, Thitithanyanont A, Wang SF. Virus-induced pathogenesis, vaccine development, and diagnosis of novel H7N9 avian influenza A virus in humans: a systemic literature review. J Int Med Res. 2020, 48:300060519845488. 10.1177\/0300060519845488","journal-title":"J Int Med Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-19996-7","article-title":"Antigenic drift and epidemiological severity of seasonal influenza in Canada","volume":"12","author":"Chen Z","year":"2022","unstructured":"Chen Z, Bancej C, Lee L, Champredon D. Antigenic drift and epidemiological severity of seasonal influenza in Canada. Sci Rep. 2022, 12:15625. 10.1038\/s41598-022-19996-7","journal-title":"Sci Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11296-5","article-title":"Repeat vaccination reduces antibody affinity maturation across different influenza vaccine platforms in humans","volume":"1","author":"Khurana S","year":"2019","unstructured":"Khurana S, Hahn M, Coyle EM, et al.. Repeat vaccination reduces antibody affinity maturation across different influenza vaccine platforms in humans. Nat Commun. 2019, 1:41467-019. 10.1038\/s41467-019-11296-5","journal-title":"Nat Commun"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-021-03806-6","article-title":"Antigenic characterization of influenza and SARS-CoV-2 viruses","volume":"414","author":"Wang Y","year":"2022","unstructured":"Wang Y, Tang CY, Wan XF. Antigenic characterization of influenza and SARS-CoV-2 viruses. Anal Bioanal Chem. 2022, 414:2841-81. 10.1007\/s00216-021-03806-6","journal-title":"Anal Bioanal Chem"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.793500","article-title":"Reassortment network of influenza A virus","volume":"12","author":"Gong X","year":"2021","unstructured":"Gong X, Hu M, Chen W, et al.. Reassortment network of influenza A virus. Front Microbiol. 2021, 12:793500. 10.3389\/fmicb.2021.793500","journal-title":"Front Microbiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.104771","article-title":"Respiratory syncytial virus","author":"Talukdar SN","year":"2022","unstructured":"Talukdar SN, Mehedi M. Respiratory syncytial virus. IntechOpen. 2022, 10.5772\/intechopen.104771","journal-title":"IntechOpen"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.865592","article-title":"Innate immune evasion by human respiratory syncytial virus","volume":"13","author":"Ouyang Y","year":"2022","unstructured":"Ouyang Y, Liao H, Hu Y, Luo K, Hu S, Zhu H. Innate immune evasion by human respiratory syncytial virus. Front Microbiol. 2022, 13:10.3389\/fmicb.2022.865592","journal-title":"Front Microbiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix070","article-title":"Respiratory syncytial virus (RSV) infects CD4+ T cells: frequency of circulating CD4+ RSV+ T cells as a marker of disease severity in young children","volume":"215","author":"Raiden S","year":"2017","unstructured":"Raiden S, Sananez I, Remes-Lenicov F, et al.. Respiratory syncytial virus (RSV) infects CD4+ T cells: frequency of circulating CD4+ RSV+ T cells as a marker of disease severity in young children. J Infect Dis. 2017, 215:1049-58. 10.1093\/infdis\/jix070","journal-title":"J Infect Dis"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/mmi.15133","article-title":"Respiratory syncytial virus entry mechanism in host cells: a general overview","volume":"120","author":"Cadena-Cruz C","year":"2023","unstructured":"Cadena-Cruz C, Villarreal Camacho JL, De \u00c1vila-Arias M, Hurtado-Gomez L, Rodriguez A, San-Juan-Vergara H. Respiratory syncytial virus entry mechanism in host cells: a general overview. Mol Microbiol. 2023, 120:341-50. 10.1111\/mmi.15133","journal-title":"Mol Microbiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1038\/s44298-024-00075-9","article-title":"Respiratory syncytial virus glycoprotein G impedes CX3CR1-activation by CX3CL1 and monocyte function","volume":"63","author":"Meineke R","year":"2024","unstructured":"Meineke R, Agac A, Knittler MC, et al.. Respiratory syncytial virus glycoprotein G impedes CX3CR1-activation by CX3CL1 and monocyte function. npj Viruses. 2024, 63:10.1038\/s44298-024-00075-9","journal-title":"npj Viruses"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12080","article-title":"Routes of influenza transmission","volume":"7","author":"Killingley B","year":"2013","unstructured":"Killingley B, Nguyen\u2010Van\u2010Tam J. Routes of influenza transmission. Influenza Other Respir Viruses. 2013, 7:42-51. 10.1111\/irv.12080","journal-title":"Influenza Other Respir Viruses"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.36342","article-title":"Respiratory syncytial virus: a comprehensive review of transmission, pathophysiology, and manifestation","volume":"15","author":"Kaler J","year":"2023","unstructured":"Kaler J, Hussain A, Patel K, Hernandez T, Ray S. Respiratory syncytial virus: a comprehensive review of transmission, pathophysiology, and manifestation. Cureus. 2023, 15:e36342. 10.7759\/cureus.36342","journal-title":"Cureus"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2079322","article-title":"RSV disease in infants and young children: can we see a brighter future?","volume":"18","author":"Baraldi E","year":"2022","unstructured":"Baraldi E, Checcucci Lisi G, Costantino C, et al.. RSV disease in infants and young children: can we see a brighter future?. Hum Vaccin Immunother. 2022, 18:2079322. 10.1080\/21645515.2022.2079322","journal-title":"Hum Vaccin Immunother"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103352","article-title":"Global outbreaks of respiratory syncytial virus infections from 1960 to 2025: a systematic review and meta-analysis","volume":"86","author":"Duan Q","year":"2025","unstructured":"Duan Q, Pan J, Zheng L, et al.. Global outbreaks of respiratory syncytial virus infections from 1960 to 2025: a systematic review and meta-analysis. EClinicalMedicine. 2025, 86:103352. 10.1016\/j.eclinm.2025.103352","journal-title":"EClinicalMedicine"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-11-234","article-title":"Assessing secondary attack rates among household contacts at the beginning of the influenza A (H1N1) pandemic in Ontario, Canada, April-June 2009: a prospective, observational study","volume":"11","author":"Savage R","year":"2011","unstructured":"Savage R, Whelan M, Johnson I, et al.. Assessing secondary attack rates among household contacts at the beginning of the influenza A (H1N1) pandemic in Ontario, Canada, April-June 2009: a prospective, observational study. BMC Public Health. 2011, 11:234. 10.1186\/1471-2458-11-234","journal-title":"BMC Public Health"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02152","article-title":"Host components contributing to respiratory syncytial virus pathogenesis","volume":"10","author":"Carvajal JJ","year":"2019","unstructured":"Carvajal JJ, Avellaneda AM, Salazar-Ardiles C, Maya JE, Kalergis AM, Lay MK. Host components contributing to respiratory syncytial virus pathogenesis. Front Immunol. 2019, 10:2152. 10.3389\/fimmu.2019.02152","journal-title":"Front Immunol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.dci.2022.104368","article-title":"Exosomes from H5N1 avian influenza virus-infected chickens regulate antiviral immune responses of chicken immune cells","volume":"130","author":"Hong Y","year":"2022","unstructured":"Hong Y, Truong AD, Vu TH, et al.. Exosomes from H5N1 avian influenza virus-infected chickens regulate antiviral immune responses of chicken immune cells. Dev Comp Immunol. 2022, 130:104368. 10.1016\/j.dci.2022.104368","journal-title":"Dev Comp Immunol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1038\/nm1477","article-title":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia","volume":"12","author":"de Jong MD","year":"2006","unstructured":"de Jong MD, Simmons CP, Thanh TT, et al.. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med. 2006, 12:1203-7. 10.1038\/nm1477","journal-title":"Nat Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(13)70286-X","article-title":"Pathogenesis of influenza-induced acute respiratory distress syndrome","volume":"14","author":"Short KR","year":"2014","unstructured":"Short KR, Kroeze EJ, Fouchier RA, Kuiken T. Pathogenesis of influenza-induced acute respiratory distress syndrome. Lancet Infect Dis. 2014, 14:57-69. 10.1016\/S1473-3099(13)70286-X","journal-title":"Lancet Infect Dis"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1400593111","article-title":"Mapping the innate signaling cascade essential for cytokine storm during influenza virus infection","volume":"111","author":"Teijaro JR","year":"2014","unstructured":"Teijaro JR, Walsh KB, Rice S, Rosen H, Oldstone MB. Mapping the innate signaling cascade essential for cytokine storm during influenza virus infection. Proc Natl Acad Sci U S A. 2014, 111:3799-804. 10.1073\/pnas.1400593111","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.120.315698","article-title":"Platelet activation and plasma levels of furin are associated with prognosis of patients with coronary artery disease and COVID-19","volume":"41","author":"Langnau C","year":"2021","unstructured":"Langnau C, Rohlfing AK, Gekeler S, et al.. Platelet activation and plasma levels of furin are associated with prognosis of patients with coronary artery disease and COVID-19. Arterioscler Thromb Vasc Biol. 2021, 41:2080-96. 10.1161\/ATVBAHA.120.315698","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00368.2013","article-title":"EGFR activation suppresses respiratory virus-induced IRF1-dependent CXCL10 production","volume":"307","author":"Kalinowski A","year":"2014","unstructured":"Kalinowski A, Ueki I, Min-Oo G, et al.. EGFR activation suppresses respiratory virus-induced IRF1-dependent CXCL10 production. Am J Physiol Lung Cell Mol Physiol. 2014, 307:186-96. 10.1152\/ajplung.00368.2013","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1220028","article-title":"Transcriptomic profiles of multiple organ dysfunction syndrome phenotypes in pediatric critical influenza","volume":"14","author":"Novak T","year":"2023","unstructured":"Novak T, Crawford JC, Hahn G, et al.. Transcriptomic profiles of multiple organ dysfunction syndrome phenotypes in pediatric critical influenza. Front Immunol. 2023, 14:1220028. 10.3389\/fimmu.2023.1220028","journal-title":"Front Immunol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-018-0335-0","article-title":"Whole transcriptome analysis reveals differential gene expression profile reflecting macrophage polarization in response to influenza A H5N1 virus infection","volume":"11","author":"Zhang N","year":"2018","unstructured":"Zhang N, Bao YJ, Tong AH, et al.. Whole transcriptome analysis reveals differential gene expression profile reflecting macrophage polarization in response to influenza A H5N1 virus infection. BMC Med Genomics. 2018, 11:20. 10.1186\/s12920-018-0335-0","journal-title":"BMC Med Genomics"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1172\/JCI18921","article-title":"C-reactive protein: a critical update","volume":"111","author":"Pepys MB","year":"2003","unstructured":"Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003, 111:1805-12. 10.1172\/JCI18921","journal-title":"J Clin Invest"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-023-01176-0","article-title":"Comparative analysis of CRP as a biomarker of the inflammatory response intensity among common viral infections affecting the lungs: COVID-19 versus influenza A, influenza B and respiratory syncytial virus","volume":"23","author":"Levinson T","year":"2023","unstructured":"Levinson T, Wasserman A, Shenhar-Tsarfaty S, et al.. Comparative analysis of CRP as a biomarker of the inflammatory response intensity among common viral infections affecting the lungs: COVID-19 versus influenza A, influenza B and respiratory syncytial virus. Clin Exp Med. 2023, 23:5307-13. 10.1007\/s10238-023-01176-0","journal-title":"Clin Exp Med"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxx031","article-title":"Hyperferritinemia and inflammation","volume":"29","author":"Kernan KF","year":"2017","unstructured":"Kernan KF, Carcillo JA. Hyperferritinemia and inflammation. Int Immunol. 2017, 29:401-9. 10.1093\/intimm\/dxx031","journal-title":"Int Immunol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.23354","article-title":"Review: viral infections and mechanisms of thrombosis and bleeding","volume":"84","author":"Goeijenbier M","year":"2012","unstructured":"Goeijenbier M, van Wissen M, van de Weg C, et al.. Review: viral infections and mechanisms of thrombosis and bleeding. J Med Virol. 2012, 84:1680-96. 10.1002\/jmv.23354","journal-title":"J Med Virol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2016.1","article-title":"Aberrant coagulation causes a hyper-inflammatory response in severe influenza pneumonia","volume":"13","author":"Yang Y","year":"2016","unstructured":"Yang Y, Tang H. Aberrant coagulation causes a hyper-inflammatory response in severe influenza pneumonia. Cell Mol Immunol. 2016, 13:432-42. 10.1038\/cmi.2016.1","journal-title":"Cell Mol Immunol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.03027-23","article-title":"Lymphocyte and neutrophil count combined with intestinal bacteria abundance predict the severity of COVID-19","volume":"12","author":"Chen L","year":"2024","unstructured":"Chen L, Yin Z, Zhou D, et al.. Lymphocyte and neutrophil count combined with intestinal bacteria abundance predict the severity of COVID-19. Microbiol Spectr. 2024, 12:e0302723. 10.1128\/spectrum.03027-23","journal-title":"Microbiol Spectr"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2016.702","article-title":"The neutrophil-to-lymphocyte ratio: a narrative review","volume":"10","author":"Faria SS","year":"2016","unstructured":"Faria SS, Fernandes PC Jr, Silva MJ, et al.. The neutrophil-to-lymphocyte ratio: a narrative review. Ecancermedicalscience. 2016, 10:702. 10.3332\/ecancer.2016.702","journal-title":"Ecancermedicalscience"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004869","article-title":"Host transcriptional response to influenza and other acute respiratory viral infections-a prospective cohort study","volume":"11","author":"Zhai Y","year":"2015","unstructured":"Zhai Y, Franco LM, Atmar RL, et al.. Host transcriptional response to influenza and other acute respiratory viral infections-a prospective cohort study. PLoS Pathog. 2015, 11:e1004869. 10.1371\/journal.ppat.1004869","journal-title":"PLoS Pathog"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2016.01.002","article-title":"Integrated omics analysis of pathogenic host responses during pandemic H1N1 influenza virus infection: the crucial role of lipid metabolism","volume":"19","author":"Tisoncik-Go J","year":"2016","unstructured":"Tisoncik-Go J, Gasper DJ, Kyle JE, et al.. Integrated omics analysis of pathogenic host responses during pandemic H1N1 influenza virus infection: the crucial role of lipid metabolism. Cell Host Microbe. 2016, 19:254-66. 10.1016\/j.chom.2016.01.002","journal-title":"Cell Host Microbe"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.632798","article-title":"Comprehensive transcriptomic analysis identifies novel antiviral factors against influenza A virus infection","volume":"12","author":"Zhou A","year":"2021","unstructured":"Zhou A, Dong X, Liu M, Tang B. Comprehensive transcriptomic analysis identifies novel antiviral factors against influenza A virus infection. Front Immunol. 2021, 12:632798. 10.3389\/fimmu.2021.632798","journal-title":"Front Immunol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.5b00927","article-title":"Ion-current-based temporal proteomic profiling of influenza-A-virus-infected mouse lungs revealed underlying mechanisms of altered integrity of the lung microvascular barrier","volume":"15","author":"Shen S","year":"2016","unstructured":"Shen S, Li J, Hilchey S, et al.. Ion-current-based temporal proteomic profiling of influenza-A-virus-infected mouse lungs revealed underlying mechanisms of altered integrity of the lung microvascular barrier. J Proteome Res. 2016, 15:540-53. 10.1021\/acs.jproteome.5b00927","journal-title":"J Proteome Res"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens6020025","article-title":"Influenza-omics and the host response: recent advances and future prospects","volume":"6","author":"Powell JD","year":"2017","unstructured":"Powell JD, Waters KM. Influenza-omics and the host response: recent advances and future prospects. Pathogens. 2017, 6:25. 10.3390\/pathogens6020025","journal-title":"Pathogens"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2 drives development of COVID-19","volume":"181","author":"Blanco-Melo D","year":"2020","unstructured":"Blanco-Melo D, Nilsson-Payant BE, Liu WC, et al.. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell. 2020, 181:1036-45. 10.1016\/j.cell.2020.04.026","journal-title":"Cell"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.3390\/biom15070977","article-title":"Incidence of circulating antibodies against hemagglutinin of influenza viruses in epidemic season 2023\/2024 in Poland","volume":"15","author":"Kondratiuk K","year":"2025","unstructured":"Kondratiuk K, Masny A, Pozna\u0144ska A, et al.. Incidence of circulating antibodies against hemagglutinin of influenza viruses in epidemic season 2023\/2024 in Poland. Biomolecules. 2025, 15:977. 10.3390\/biom15070977","journal-title":"Biomolecules"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25116178","article-title":"Immune response to respiratory viral infections","volume":"25","author":"Gambadauro A","year":"2024","unstructured":"Gambadauro A, Galletta F, Li Pomi A, Manti S, Piedimonte G. Immune response to respiratory viral infections. Int J Mol Sci. 2024, 25:6178. 10.3390\/ijms25116178","journal-title":"Int J Mol Sci"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-024-01011-x","article-title":"Boosting neuraminidase immunity in the presence of hemagglutinin with the next generation of influenza vaccines","volume":"9","author":"Cort\u00e9s G","year":"2024","unstructured":"Cort\u00e9s G, Ustyugova I, Farrell T, et al.. Boosting neuraminidase immunity in the presence of hemagglutinin with the next generation of influenza vaccines. NPJ Vaccines. 2024, 9:228. 10.1038\/s41541-024-01011-x","journal-title":"NPJ Vaccines"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-024-04822-y","article-title":"Diagnostic value of routine blood tests in differentiating between SARS-CoV-2, influenza A, and RSV infections in hospitalized children: a retrospective study","volume":"24","author":"Huang L","year":"2024","unstructured":"Huang L, Ye C, Zhou R, Ji Z. Diagnostic value of routine blood tests in differentiating between SARS-CoV-2, influenza A, and RSV infections in hospitalized children: a retrospective study. BMC Pediatr. 2024, 24:328. 10.1186\/s12887-024-04822-y","journal-title":"BMC Pediatr"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1361323","article-title":"A ferritin nanoparticle vaccine based on the hemagglutinin extracellular domain of swine influenza A (H1N1) virus elicits protective immune responses in mice and pigs","volume":"15","author":"Tang P","year":"2024","unstructured":"Tang P, Cui E, Cheng J, et al.. A ferritin nanoparticle vaccine based on the hemagglutinin extracellular domain of swine influenza A (H1N1) virus elicits protective immune responses in mice and pigs. Front Immunol. 2024, 15:1361323. 10.3389\/fimmu.2024.1361323","journal-title":"Front Immunol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.3390\/v15061245","article-title":"New generation of systemic inflammatory markers for respiratory syncytial virus infection in children","volume":"15","author":"Okuyan O","year":"2023","unstructured":"Okuyan O, Elgormus Y, Dumur S, Sayili U, Uzun H. New generation of systemic inflammatory markers for respiratory syncytial virus infection in children. Viruses. 2023, 15:1245. 10.3390\/v15061245","journal-title":"Viruses"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0280825","article-title":"Anti-neuraminidase and anti-hemagglutinin immune serum can confer inter-lineage cross protection against recent influenza B","volume":"18","author":"Portela Catani JP","year":"2023","unstructured":"Portela Catani JP, Ysenbaert T, Smet A, Vuylsteke M, Vogel TU, Saelens X. Anti-neuraminidase and anti-hemagglutinin immune serum can confer inter-lineage cross protection against recent influenza B. PLoS One. 2023, 18:e0280825. 10.1371\/journal.pone.0280825","journal-title":"PLoS One"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa063","article-title":"Immunological and inflammatory biomarkers of susceptibility and severity in adult respiratory syncytial virus infections","volume":"222","author":"Wiseman DJ","year":"2020","unstructured":"Wiseman DJ, Thwaites RS, Drysdale SB, Janet S, Donaldson GC, Wedzicha JA, Openshaw PJ. Immunological and inflammatory biomarkers of susceptibility and severity in adult respiratory syncytial virus infections. J Infect Dis. 2020, 222:S584-91. 10.1093\/infdis\/jiaa063","journal-title":"J Infect Dis"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-020-00355-6","article-title":"Genetic influences on viral-induced cytokine responses in the lung","volume":"14","author":"Forbester JL","year":"2021","unstructured":"Forbester JL, Humphreys IR. Genetic influences on viral-induced cytokine responses in the lung. Mucosal Immunol. 2021, 14:14-25. 10.1038\/s41385-020-00355-6","journal-title":"Mucosal Immunol"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.16275","article-title":"Identification of key candidate biomarkers for severe influenza infection by integrated bioinformatical analysis and initial clinical validation","volume":"25","author":"Liu S","year":"2021","unstructured":"Liu S, Huang Z, Deng X, Zou X, Li H, Mu S, Cao B. Identification of key candidate biomarkers for severe influenza infection by integrated bioinformatical analysis and initial clinical validation. J Cell Mol Med. 2021, 25:1725-38. 10.1111\/jcmm.16275","journal-title":"J Cell Mol Med"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01423-19","article-title":"Hemagglutinin stability regulates H1N1 influenza virus replication and pathogenicity in mice by modulating type I interferon responses in dendritic cells","volume":"17","author":"Russier M","year":"2020","unstructured":"Russier M, Yang G, Briard B, et al.. Hemagglutinin stability regulates H1N1 influenza virus replication and pathogenicity in mice by modulating type I interferon responses in dendritic cells. J Virol. 2020, 17:94. 10.1128\/JVI.01423-19","journal-title":"J Virol"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.3390\/v11111048","article-title":"Phylogeny, pathogenicity, transmission, and host immune responses of four H5N6 avian influenza viruses in chickens and mice","volume":"11","author":"Song Y","year":"2019","unstructured":"Song Y, Li W, Wu W, et al.. Phylogeny, pathogenicity, transmission, and host immune responses of four H5N6 avian influenza viruses in chickens and mice. Viruses. 2019, 11:1048. 10.3390\/v11111048","journal-title":"Viruses"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0220908","article-title":"Clinical correlation of influenza and respiratory syncytial virus load measured by digital PCR","volume":"14","author":"Hijano DR","year":"2019","unstructured":"Hijano DR, Brazelton de Cardenas J, Maron G, et al.. Clinical correlation of influenza and respiratory syncytial virus load measured by digital PCR. PLoS One. 2019, 14:e0220908. 10.1371\/journal.pone.0220908","journal-title":"PLoS One"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.4103\/ijmm.IJMM_19_211","article-title":"Immune response during influenza virus infection among the population of Assam, Northeast India","volume":"37","author":"Dutta M","year":"2019","unstructured":"Dutta M, Dutta P, Medhi S, Borkakoty B, Biswas D. Immune response during influenza virus infection among the population of Assam, Northeast India. Indian J Med Microbiol. 2019, 37:549-56. 10.4103\/ijmm.IJMM_19_211","journal-title":"Indian J Med Microbiol"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01154","article-title":"Cytokines in the respiratory airway as biomarkers of severity and prognosis for respiratory syncytial virus infection: an update","volume":"10","author":"V\u00e1zquez Y","year":"2019","unstructured":"V\u00e1zquez Y, Gonz\u00e1lez L, Noguera L, Gonz\u00e1lez PA, Riedel CA, Bertrand P, Bueno SM. Cytokines in the respiratory airway as biomarkers of severity and prognosis for respiratory syncytial virus infection: an update. Front Immunol. 2019, 10:1154. 10.3389\/fimmu.2019.01154","journal-title":"Front Immunol"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.12.002","article-title":"Oral vaccination with influenza hemagglutinin combined with human pulmonary surfactant-mimicking synthetic adjuvant SF-10 induces efficient local and systemic immunity compared with nasal and subcutaneous vaccination and provides protective immunity in mice","volume":"37","author":"Kimoto T","year":"2019","unstructured":"Kimoto T, Kim H, Sakai S, Takahashi E, Kido H. Oral vaccination with influenza hemagglutinin combined with human pulmonary surfactant-mimicking synthetic adjuvant SF-10 induces efficient local and systemic immunity compared with nasal and subcutaneous vaccination and provides protective immunity in mice. Vaccine. 2019, 37:612-22. 10.1016\/j.vaccine.2018.12.002","journal-title":"Vaccine"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1186\/s13567-019-0635-1","article-title":"Study of the underlying mechanisms and consequences of pathogenicity differences between two in vitro selected G1-H9N2 clones originating from a single isolate","volume":"50","author":"Nguyen GT","year":"2019","unstructured":"Nguyen GT, Rauw F, Steensels M, Ingrao F, Bonfante F, Davidson I, Lambrecht B. Study of the underlying mechanisms and consequences of pathogenicity differences between two in vitro selected G1-H9N2 clones originating from a single isolate. Vet Res. 2019, 50:18. 10.1186\/s13567-019-0635-1","journal-title":"Vet Res"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy209.083","article-title":"967. Inhibition of host neuraminidase increases susceptibility to invasive pulmonary aspergillosis","volume":"5","author":"Van De Veerdonk F Jr","year":"2018","unstructured":"Van De Veerdonk F Jr, Dewi I, Cunha C, et al.. 967. Inhibition of host neuraminidase increases susceptibility to invasive pulmonary aspergillosis. Open Forum Infect Dis. 2018, 5:S36. 10.1093\/ofid\/ofy209.083","journal-title":"Open Forum Infect Dis"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2018.102","article-title":"A synthetic micro-consensus DNA vaccine generates comprehensive influenza A H3N2 immunity and protects mice against lethal challenge by multiple H3N2 viruses","volume":"29","author":"Elliott ST","year":"2018","unstructured":"Elliott ST, Keaton AA, Chu JD, et al.. A synthetic micro-consensus DNA vaccine generates comprehensive influenza A H3N2 immunity and protects mice against lethal challenge by multiple H3N2 viruses. Hum Gene Ther. 2018, 29:1044-55. 10.1089\/hum.2018.102","journal-title":"Hum Gene Ther"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1038\/srep45043","article-title":"Influenza A virus hemagglutinin and neuraminidase act as novel motile machinery","volume":"7","author":"Sakai T","year":"2017","unstructured":"Sakai T, Nishimura SI, Naito T, Saito M. Influenza A virus hemagglutinin and neuraminidase act as novel motile machinery. Sci Rep. 2017, 7:1-11. 10.1038\/srep45043","journal-title":"Sci Rep"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1186\/s12896-016-0321-6","article-title":"Multi-antigen avian influenza a (H7N9) virus-like particles: particulate characterizations and immunogenicity evaluation in murine and avian models","volume":"17","author":"Hu CJ","year":"2017","unstructured":"Hu CJ, Chien CY, Liu MT, et al.. Multi-antigen avian influenza a (H7N9) virus-like particles: particulate characterizations and immunogenicity evaluation in murine and avian models. BMC Biotechnol. 2017, 17:2. 10.1186\/s12896-016-0321-6","journal-title":"BMC Biotechnol"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01542","article-title":"Protective effect of Panax notoginseng root water extract against influenza a virus infection by enhancing antiviral interferon-mediated immune responses and natural killer cell activity","volume":"8","author":"Choi JG","year":"2017","unstructured":"Choi JG, Jin YH, Lee H, Oh TW, Yim NH, Cho WK, Ma JY. Protective effect of Panax notoginseng root water extract against influenza a virus infection by enhancing antiviral interferon-mediated immune responses and natural killer cell activity. Front Immunol. 2017, 8:1542. 10.3389\/fimmu.2017.01542","journal-title":"Front Immunol"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01154-17","article-title":"Phase 2 randomized trial of the safety and efficacy of MHAA4549A, a broadly neutralizing monoclonal antibody, in a human influenza A virus challenge model","volume":"61","author":"McBride JM","year":"2017","unstructured":"McBride JM, Lim JJ, Burgess T, et al.. Phase 2 randomized trial of the safety and efficacy of MHAA4549A, a broadly neutralizing monoclonal antibody, in a human influenza A virus challenge model. Antimicrob Agents Chemother. 2017, 61:e01154-17. 10.1128\/AAC.01154-17","journal-title":"Antimicrob Agents Chemother"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2016.25","article-title":"Artificial antigen-presenting cells expressing HLA class II molecules as an effective tool for amplifying human specific memory CD4(+) T cells","volume":"94","author":"Garnier A","year":"2016","unstructured":"Garnier A, Hamieh M, Drouet A, et al.. Artificial antigen-presenting cells expressing HLA class II molecules as an effective tool for amplifying human specific memory CD4(+) T cells. Immunol Cell Biol. 2016, 94:662-72. 10.1038\/icb.2016.25","journal-title":"Immunol Cell Biol"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1016\/j.prrv.2015.05.005","article-title":"Biomarkers of respiratory syncytial virus (RSV) infection: specific neutrophil and cytokine levels provide increased accuracy in predicting disease severity","volume":"16","author":"Brown PM","year":"2015","unstructured":"Brown PM, Schneeberger DL, Piedimonte G. Biomarkers of respiratory syncytial virus (RSV) infection: specific neutrophil and cytokine levels provide increased accuracy in predicting disease severity. Paediatr Respir Rev. 2015, 16:232-40. 10.1016\/j.prrv.2015.05.005","journal-title":"Paediatr Respir Rev"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M114.045401","article-title":"The viral transcription group determines the HLA class I cellular immune response against human respiratory syncytial virus","volume":"14","author":"Johnstone C","year":"2015","unstructured":"Johnstone C, Lorente E, Barriga A, et al.. The viral transcription group determines the HLA class I cellular immune response against human respiratory syncytial virus. Mol Cell Proteomics. 2015, 14:893-904. 10.1074\/mcp.M114.045401","journal-title":"Mol Cell Proteomics"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0143281","article-title":"Immune responses in acute and convalescent patients with mild, moderate and severe disease during the 2009 influenza pandemic in Norway","volume":"10","author":"Mohn KG","year":"2015","unstructured":"Mohn KG, Cox RJ, Tunheim G, et al.. Immune responses in acute and convalescent patients with mild, moderate and severe disease during the 2009 influenza pandemic in Norway. PLoS One. 2015, 10:e0143281. 10.1371\/journal.pone.0143281","journal-title":"PLoS One"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M049148","article-title":"Lipidomics identifies a requirement for peroxisomal function during influenza virus replication","volume":"55","author":"Tanner LB","year":"2014","unstructured":"Tanner LB, Chng C, Guan XL, Lei Z, Rozen SG, Wenk MR. Lipidomics identifies a requirement for peroxisomal function during influenza virus replication. J Lipid Res. 2014, 55:1357-65. 10.1194\/jlr.M049148","journal-title":"J Lipid Res"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201311-2071OC","article-title":"Low titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infection","volume":"189","author":"Guihot A","year":"2014","unstructured":"Guihot A, Luyt CE, Parrot A, et al.. Low titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infection. Am J Respir Crit Care Med. 2014, 189:1240-9. 10.1164\/rccm.201311-2071OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3182a14407","article-title":"Novel inflammatory markers, clinical risk factors and virus type associated with severe respiratory syncytial virus infection","volume":"32","author":"Tabarani CM","year":"2013","unstructured":"Tabarani CM, Bonville CA, Suryadevara M, et al.. Novel inflammatory markers, clinical risk factors and virus type associated with severe respiratory syncytial virus infection. Pediatr Infect Dis J. 2013, 32:437. 10.1097\/INF.0b013e3182a14407","journal-title":"Pediatr Infect Dis J"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0057121","article-title":"The association between serum biomarkers and disease outcome in influenza A(H1N1)pdm09 virus infection: results of two international observational cohort studies","volume":"8","author":"Davey RT Jr","year":"2013","unstructured":"Davey RT Jr, Lynfield R, Dwyer DE, et al.. The association between serum biomarkers and disease outcome in influenza A(H1N1)pdm09 virus infection: results of two international observational cohort studies. PLoS One. 2013, 8:e57121. 10.1371\/journal.pone.0057121","journal-title":"PLoS One"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01724-13","article-title":"A novel influenza virus hemagglutinin-respiratory syncytial virus (RSV) fusion protein subunit vaccine against influenza and RSV","volume":"87","author":"Turner TM","year":"2013","unstructured":"Turner TM, Jones LP, Tompkins SM, Tripp RA. A novel influenza virus hemagglutinin-respiratory syncytial virus (RSV) fusion protein subunit vaccine against influenza and RSV. J Virol. 2013, 87:10792-804. 10.1128\/JVI.01724-13","journal-title":"J Virol"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039990","article-title":"Recently emerged swine influenza A virus (H2N3) causes severe pneumonia in cynomolgus macaques","volume":"7","author":"Richt JA","year":"2012","unstructured":"Richt JA, Rockx B, Ma W, et al.. Recently emerged swine influenza A virus (H2N3) causes severe pneumonia in cynomolgus macaques. PLoS One. 2012, 7:e39990. 10.1371\/journal.pone.0039990","journal-title":"PLoS One"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042419","article-title":"Laninamivir octanoate and artificial surfactant combination therapy significantly increases survival of mice infected with lethal influenza H1N1 Virus","volume":"7","author":"Fukushi M","year":"2012","unstructured":"Fukushi M, Yamashita M, Miyoshi-Akiyama T, Kubo S, Yamamoto K, Kudo K. Laninamivir octanoate and artificial surfactant combination therapy significantly increases survival of mice infected with lethal influenza H1N1 Virus. PLoS One. 2012, 7:e42419. 10.1371\/journal.pone.0042419","journal-title":"PLoS One"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-2659.2011.00271.x","article-title":"The mucosal and systemic immune responses elicited by a chitosan-adjuvanted intranasal influenza H5N1 vaccine","volume":"6","author":"Svindland SC","year":"2012","unstructured":"Svindland SC, Jul-Larsen \u00c5, Pathirana R, et al.. The mucosal and systemic immune responses elicited by a chitosan-adjuvanted intranasal influenza H5N1 vaccine. Influenza Other Respir Viruses. 2012, 6:90-100. 10.1111\/j.1750-2659.2011.00271.x","journal-title":"Influenza Other Respir Viruses"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.4161\/cc.9.5.10913","article-title":"Genomic analysis of pandemic (H1N1) 2009 reveals association of increasing disease severity with emergence of novel hemagglutinin mutations","volume":"9","author":"Glinsky GV","year":"2010","unstructured":"Glinsky GV. Genomic analysis of pandemic (H1N1) 2009 reveals association of increasing disease severity with emergence of novel hemagglutinin mutations. Cell Cycle. 2010, 9:958-70. 10.4161\/cc.9.5.10913","journal-title":"Cell Cycle"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1186\/cc8208","article-title":"Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza","volume":"13","author":"Bermejo-Martin JF","year":"2009","unstructured":"Bermejo-Martin JF, Ortiz de Lejarazu R, Pumarola T, et al.. Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. Crit Care. 2009, 13:R201. 10.1186\/cc8208","journal-title":"Crit Care"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02602-07","article-title":"Alveolar macrophages are indispensable for controlling influenza viruses in lungs of pigs","volume":"82","author":"Kim HM","year":"2008","unstructured":"Kim HM, Lee YW, Lee KJ, et al.. Alveolar macrophages are indispensable for controlling influenza viruses in lungs of pigs. J Virol. 2008, 82:4265-74. 10.1128\/JVI.02602-07","journal-title":"J Virol"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1086\/512615","article-title":"Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses","volume":"195","author":"Welliver TP","year":"2007","unstructured":"Welliver TP, Garofalo RP, Hosakote Y, et al.. Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J Infect Dis. 2007, 195:1126-36. 10.1086\/512615","journal-title":"J Infect Dis"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.864","article-title":"Protection against influenza infection by cytokine-enhanced aerosol genetic immunization","volume":"8","author":"Orson FM","year":"2006","unstructured":"Orson FM, Kinsey BM, Densmore CL, Nguyen T, Wu Y, Mbawuike IN, Wyde PR. Protection against influenza infection by cytokine-enhanced aerosol genetic immunization. J Gene Med. 2006, 8:488-97. 10.1002\/jgm.864","journal-title":"J Gene Med"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M507553200","article-title":"Acetylation of poly(ADP-ribose) polymerase-1 by p300\/CREB-binding protein regulates coactivation of NF-kappaB-dependent transcription","volume":"280","author":"Hassa PO","year":"2005","unstructured":"Hassa PO, Haenni SS, Buerki C, et al.. Acetylation of poly(ADP-ribose) polymerase-1 by p300\/CREB-binding protein regulates coactivation of NF-kappaB-dependent transcription. J Biol Chem. 2005, 280:40450-64. 10.1074\/jbc.M507553200","journal-title":"J Biol Chem"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/441685-circulating-viral-antigenic-proteins-and-inflammatory-biomarkers-in-influenza-and-respiratory-syncytial-virus-infections-associations-with-disease-severity-and-transmission","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T06:09:01Z","timestamp":1766642941000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/441685-circulating-viral-antigenic-proteins-and-inflammatory-biomarkers-in-influenza-and-respiratory-syncytial-virus-infections-associations-with-disease-severity-and-transmission"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":94,"URL":"https:\/\/doi.org\/10.7759\/cureus.100037","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,24]]}}}